vs
南玻集团（CSGS）与Lantheus Holdings, Inc.（LNTH）财务数据对比。点击上方公司名可切换其他公司
Lantheus Holdings, Inc.的季度营收约是南玻集团的1.3倍（$406.8M vs $323.1M），Lantheus Holdings, Inc.净利率更高（13.3% vs 2.2%，领先11.1%），Lantheus Holdings, Inc.同比增速更快（4.0% vs 2.0%），Lantheus Holdings, Inc.自由现金流更多（$81.4M vs $55.8M），过去两年Lantheus Holdings, Inc.的营收复合增速更高（4.9% vs 4.6%）
中国南玻集团股份有限公司是中国规模最大的建筑玻璃生产商，业务涵盖浮法玻璃、建筑玻璃、显示玻璃、汽车玻璃、镀膜玻璃、镜子、彩滤玻璃、太阳能玻璃及节能玻璃等各类玻璃产品的研发、生产与销售，产品广泛应用于建筑、消费电子、新能源汽车、光伏等多个领域。
Lantheus Holdings是一家全球性医疗保健企业，专注于研发、生产及商业化创新诊断显像剂与相关解决方案，产品覆盖肿瘤学、心脏病学、泌尿学等核心医疗领域，主要市场遍及北美及全球其他重点地区。
CSGS vs LNTH — 直观对比
营收规模更大
LNTH
是对方的1.3倍
$323.1M
营收增速更快
LNTH
高出2.0%
2.0%
净利率更高
LNTH
高出11.1%
2.2%
自由现金流更多
LNTH
多$25.6M
$55.8M
两年增速更快
LNTH
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $323.1M | $406.8M |
| 净利润 | $7.0M | $54.1M |
| 毛利率 | 50.0% | 59.2% |
| 营业利润率 | 9.0% | 19.0% |
| 净利率 | 2.2% | 13.3% |
| 营收同比 | 2.0% | 4.0% |
| 净利润同比 | -79.7% | 558.8% |
| 每股收益（稀释后） | $0.24 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSGSLNTH
| Q4 25 | $323.1M | $406.8M | ||
| Q3 25 | $303.6M | $384.0M | ||
| Q2 25 | $297.1M | $378.0M | ||
| Q1 25 | $299.5M | $372.8M | ||
| Q4 24 | $316.7M | $391.1M | ||
| Q3 24 | $295.1M | $378.7M | ||
| Q2 24 | $290.3M | $394.1M | ||
| Q1 24 | $295.1M | $370.0M |
净利润CSGSLNTH
| Q4 25 | $7.0M | $54.1M | ||
| Q3 25 | $20.5M | $27.8M | ||
| Q2 25 | $12.3M | $78.8M | ||
| Q1 25 | $16.1M | $72.9M | ||
| Q4 24 | $34.5M | $-11.8M | ||
| Q3 24 | $19.1M | $131.1M | ||
| Q2 24 | $13.8M | $62.1M | ||
| Q1 24 | $19.5M | $131.1M |
毛利率CSGSLNTH
| Q4 25 | 50.0% | 59.2% | ||
| Q3 25 | 48.1% | 57.9% | ||
| Q2 25 | 49.5% | 63.8% | ||
| Q1 25 | 48.4% | 63.8% | ||
| Q4 24 | 51.3% | 63.5% | ||
| Q3 24 | 49.4% | 63.9% | ||
| Q2 24 | 47.3% | 64.9% | ||
| Q1 24 | 46.5% | 65.4% |
营业利润率CSGSLNTH
| Q4 25 | 9.0% | 19.0% | ||
| Q3 25 | 10.0% | 11.4% | ||
| Q2 25 | 10.0% | 23.3% | ||
| Q1 25 | 9.8% | 27.4% | ||
| Q4 24 | 13.4% | 29.1% | ||
| Q3 24 | 10.8% | 35.3% | ||
| Q2 24 | 8.8% | 26.1% | ||
| Q1 24 | 10.8% | 28.8% |
净利率CSGSLNTH
| Q4 25 | 2.2% | 13.3% | ||
| Q3 25 | 6.7% | 7.2% | ||
| Q2 25 | 4.1% | 20.8% | ||
| Q1 25 | 5.4% | 19.6% | ||
| Q4 24 | 10.9% | -3.0% | ||
| Q3 24 | 6.5% | 34.6% | ||
| Q2 24 | 4.8% | 15.8% | ||
| Q1 24 | 6.6% | 35.4% |
每股收益（稀释后）CSGSLNTH
| Q4 25 | $0.24 | $0.86 | ||
| Q3 25 | $0.73 | $0.41 | ||
| Q2 25 | $0.44 | $1.12 | ||
| Q1 25 | $0.57 | $1.02 | ||
| Q4 24 | $1.20 | $-0.18 | ||
| Q3 24 | $0.67 | $1.79 | ||
| Q2 24 | $0.48 | $0.88 | ||
| Q1 24 | $0.68 | $1.87 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.0M | $359.1M |
| 总债务越低越好 | $539.5M | $568.7M |
| 股东权益账面价值 | $283.7M | $1.1B |
| 总资产 | $1.5B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.90× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资CSGSLNTH
| Q4 25 | $180.0M | $359.1M | ||
| Q3 25 | $158.4M | $382.0M | ||
| Q2 25 | $145.9M | $695.6M | ||
| Q1 25 | $136.0M | $938.5M | ||
| Q4 24 | $161.8M | $912.8M | ||
| Q3 24 | $118.4M | $866.4M | ||
| Q2 24 | $110.4M | $757.0M | ||
| Q1 24 | $120.8M | $718.3M |
总债务CSGSLNTH
| Q4 25 | $539.5M | $568.7M | ||
| Q3 25 | $538.6M | $567.9M | ||
| Q2 25 | $537.8M | $566.8M | ||
| Q1 25 | $537.6M | $566.1M | ||
| Q4 24 | $538.5M | $565.3M | ||
| Q3 24 | $539.5M | $613.0K | ||
| Q2 24 | $540.5M | $563.2M | ||
| Q1 24 | $541.5M | $562.5M |
股东权益CSGSLNTH
| Q4 25 | $283.7M | $1.1B | ||
| Q3 25 | $289.5M | $1.1B | ||
| Q2 25 | $290.7M | $1.2B | ||
| Q1 25 | $283.1M | $1.2B | ||
| Q4 24 | $282.6M | $1.1B | ||
| Q3 24 | $288.4M | $1.2B | ||
| Q2 24 | $273.3M | $1.0B | ||
| Q1 24 | $269.3M | $945.5M |
总资产CSGSLNTH
| Q4 25 | $1.5B | $2.2B | ||
| Q3 25 | $1.5B | $2.3B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.4B | $2.1B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.4B | $2.0B | ||
| Q2 24 | $1.4B | $1.9B | ||
| Q1 24 | $1.3B | $1.8B |
负债/权益比CSGSLNTH
| Q4 25 | 1.90× | 0.52× | ||
| Q3 25 | 1.86× | 0.51× | ||
| Q2 25 | 1.85× | 0.49× | ||
| Q1 25 | 1.90× | 0.49× | ||
| Q4 24 | 1.91× | 0.52× | ||
| Q3 24 | 1.87× | 0.00× | ||
| Q2 24 | 1.98× | 0.55× | ||
| Q1 24 | 2.01× | 0.59× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.2M | $90.2M |
| 自由现金流经营现金流 - 资本支出 | $55.8M | $81.4M |
| 自由现金流率自由现金流/营收 | 17.3% | 20.0% |
| 资本支出强度资本支出/营收 | 1.1% | 2.2% |
| 现金转化率经营现金流/净利润 | 8.46× | 1.67× |
| 过去12个月自由现金流最近4个季度 | $141.4M | $354.1M |
8季度趋势，按日历期对齐
经营现金流CSGSLNTH
| Q4 25 | $59.2M | $90.2M | ||
| Q3 25 | $47.9M | $105.3M | ||
| Q2 25 | $37.3M | $87.1M | ||
| Q1 25 | $11.5M | $107.6M | ||
| Q4 24 | $82.5M | $157.7M | ||
| Q3 24 | $39.5M | $175.1M | ||
| Q2 24 | $43.1M | $84.7M | ||
| Q1 24 | $-29.4M | $127.2M |
自由现金流CSGSLNTH
| Q4 25 | $55.8M | $81.4M | ||
| Q3 25 | $43.9M | $94.7M | ||
| Q2 25 | $34.6M | $79.1M | ||
| Q1 25 | $7.1M | $98.8M | ||
| Q4 24 | $76.6M | $141.4M | ||
| Q3 24 | $32.0M | $159.3M | ||
| Q2 24 | $38.8M | $73.5M | ||
| Q1 24 | $-34.1M | $119.0M |
自由现金流率CSGSLNTH
| Q4 25 | 17.3% | 20.0% | ||
| Q3 25 | 14.5% | 24.7% | ||
| Q2 25 | 11.6% | 20.9% | ||
| Q1 25 | 2.4% | 26.5% | ||
| Q4 24 | 24.2% | 36.1% | ||
| Q3 24 | 10.8% | 42.0% | ||
| Q2 24 | 13.4% | 18.7% | ||
| Q1 24 | -11.6% | 32.2% |
资本支出强度CSGSLNTH
| Q4 25 | 1.1% | 2.2% | ||
| Q3 25 | 1.3% | 2.8% | ||
| Q2 25 | 0.9% | 2.1% | ||
| Q1 25 | 1.5% | 2.3% | ||
| Q4 24 | 1.9% | 4.2% | ||
| Q3 24 | 2.5% | 4.2% | ||
| Q2 24 | 1.5% | 2.8% | ||
| Q1 24 | 1.6% | 2.2% |
现金转化率CSGSLNTH
| Q4 25 | 8.46× | 1.67× | ||
| Q3 25 | 2.34× | 3.79× | ||
| Q2 25 | 3.04× | 1.11× | ||
| Q1 25 | 0.71× | 1.47× | ||
| Q4 24 | 2.39× | — | ||
| Q3 24 | 2.07× | 1.34× | ||
| Q2 24 | 3.12× | 1.36× | ||
| Q1 24 | -1.51× | 0.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
